ACTUATE THERAPEUTICS, INC.

ACTU · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.1B · 12 employees
37
SEC Filings
$1.52
Close 2026-07-07
12
Employees

Business Summary

PART I . Overview Class-Leading GSK-3 Inhibitor We are a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). We are developing elraglusib, an ATP-competitive small molecule that is designed to enter cancer cells and block the function of the enzyme glycogen synthase kinase-3 beta (GSK-3), a master regulator of complex biological signaling cascades, inclu...

Latest Stock Quote

ACTU 2026-07-07 $1.52 O:$1.37 H:$1.54 L:$1.37 Vol:0.1M VWAP:$1.4631
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-09-13

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-262025-12-310001683168-26-002257EDGAR79K words
2025-03-132024-12-310001683168-25-001581EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001683168-25-008323EDGAR24K words
2025-08-142025-06-300001683168-25-006159EDGAR
2025-05-152025-03-310001683168-25-003705EDGAR
2024-11-132024-09-300001683168-24-007971EDGAR
2024-09-242024-06-300001683168-24-006623EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-07-170001683168-26-005616EDGAR1K words
2026-01-120001683168-26-000217EDGAR1K words
2025-11-280001683168-25-008732EDGAR
2025-11-210001683168-25-008618EDGAR
2025-09-100001683168-25-006831EDGAR
2025-06-260001683168-25-004766EDGAR
2025-06-050001683168-25-004258EDGAR
2025-06-020001683168-25-004117EDGAR
2025-05-230001683168-25-003995EDGAR
2025-05-060001683168-25-003163EDGAR

37 total filings indexed. 20 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001652935
TickerACTU
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.actuatetherapeutics.com
Listed2024-08-13

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: f052d5ad2621300e60cd10d942a4de1ca4afc02c0b3407f235300b6d5768e9b2
parent: c4897c8f309b58663f9b0f08b219772308bf697fb74f852c9d1f02d4f8919fb1
content hash: 043eb3a79f94caf50448c5018e85dff901f1b454e0f070d8824d5f2c629e8d88
signed: 2026-08-10T12:00:16.047Z
sources: 7 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up ACTU using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on ACTU, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/ACTU (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.